Detalhe da pesquisa
1.
Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia.
J Antimicrob Chemother
; 2024 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38727613
2.
Tocilizumab Dose Tapering Based on a Model-Based Algorithm is Feasible in Clinical Practice: A Short Communication.
Ther Drug Monit
; 46(3): 410-414, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38287880
3.
Paromomycin and Miltefosine Combination as an Alternative to Treat Patients With Visceral Leishmaniasis in Eastern Africa: A Randomized, Controlled, Multicountry Trial.
Clin Infect Dis
; 76(3): e1177-e1185, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36164254
4.
Pyronaridine: a review of its clinical pharmacology in the treatment of malaria.
J Antimicrob Chemother
; 78(10): 2406-2418, 2023 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37638690
5.
Population pharmacokinetics of a combination of miltefosine and paromomycin in Eastern African children and adults with visceral leishmaniasis.
J Antimicrob Chemother
; 78(11): 2702-2714, 2023 11 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37726401
6.
Optimizing carboplatin dosing by an improved prediction of carboplatin clearance using a CT-enhanced estimate of renal function.
Br J Clin Pharmacol
; 89(10): 3016-3025, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37194167
7.
Development of a Therapeutic Drug Monitoring Strategy for the Optimization of Vincristine Treatment in Pediatric Oncology Populations in Africa.
Ther Drug Monit
; 45(3): 354-363, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36917736
8.
Bioanalytical methods for pharmacokinetic studies of antileishmanial drugs.
Biomed Chromatogr
; 37(7): e5519, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36208186
9.
Everolimus Concentration in Saliva to Predict Stomatitis: A Feasibility Study in Patients with Cancer.
Ther Drug Monit
; 44(4): 520-526, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35094002
10.
Blood Parasite Load as an Early Marker to Predict Treatment Response in Visceral Leishmaniasis in Eastern Africa.
Clin Infect Dis
; 73(5): 775-782, 2021 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33580234
11.
Toxicity of pemetrexed during renal impairment explained-Implications for safe treatment.
Int J Cancer
; 149(8): 1576-1584, 2021 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34181276
12.
Low antileishmanial drug exposure in HIV-positive visceral leishmaniasis patients on antiretrovirals: an Ethiopian cohort study.
J Antimicrob Chemother
; 76(5): 1258-1268, 2021 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33677546
13.
Investigating the influence of relevant pharmacogenetic variants on the pharmacokinetics and pharmacodynamics of orally administered docetaxel combined with ritonavir.
Pharmacogenomics J
; 21(3): 336-345, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33649517
14.
Characterizing the non-linear pharmacokinetics of miltefosine in paediatric visceral leishmaniasis patients from Eastern Africa.
J Antimicrob Chemother
; 75(11): 3260-3268, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32780098
15.
Quantification of the pharmacokinetic-toxicodynamic relationship of oral docetaxel co-administered with ritonavir.
Invest New Drugs
; 38(5): 1526-1532, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32306204
16.
Evaluation of Extrapolation Methods to Predict Trough Concentrations to Guide Therapeutic Drug Monitoring of Oral Anticancer Drugs.
Ther Drug Monit
; 42(4): 532-539, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32384536
17.
Pharmacokinetics, Safety, and Efficacy of an Allometric Miltefosine Regimen for the Treatment of Visceral Leishmaniasis in Eastern African Children: An Open-label, Phase II Clinical Trial.
Clin Infect Dis
; 68(9): 1530-1538, 2019 04 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-30188978
18.
Systematic Review of Host-Mediated Activity of Miltefosine in Leishmaniasis through Immunomodulation.
Antimicrob Agents Chemother
; 63(7)2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31036692
19.
Exposure to Docetaxel in the Elderly Patient Population: a Population Pharmacokinetic Study.
Pharm Res
; 36(12): 181, 2019 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31732882
20.
Does Older Age Lead to Higher Risk for Neutropenia in Patients Treated with Paclitaxel?
Pharm Res
; 36(12): 163, 2019 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31617004